Homoeopathic medicine for chronic inflammation of nose and sinus
- Conditions
- Health Condition 1: J329- Chronic sinusitis, unspecified
- Registration Number
- CTRI/2024/07/069845
- Lead Sponsor
- The Calcutta Homoeopathic Medical College and Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
1.Patients of both sexes2.Patients of age between 18 to 65 years 3.Patient having chronic rhinosinusitis (CRS) [ICD-11 CA0A.Y] since 12 weeks or more, fulfilling the diagnostic criteria of AAO-HNS50 4.Case presenting with complaints like running nose, headache etc of chronic rhinosinusitis by using SINONASAL OUTCOME TEST (SNOT22)5.Patients undergoing X Ray paranasal sinus which show finding of chronic rhinosinusitis
6.Patients who have not taken any treatment since last 2 weeks for CRS 7.Patients who are literate, can read bengali, hindi, english, capable of filling the questionnaire 8.Providing written informed consent voluntarily
1.Cases suffering from uncontrolled systemic illness or life-threatening infections2.Cases suffering from complications of CRS 3.Cases insisting for or in need of surgical interventions, major ENT surgery within last 6 months4.Patients with previous history of nose surgery5.Patients having DNS, cleft lip, otitis media6.Patients who are undergoing treatment with antibiotics, glucocorticoids or antihistamines during 2 weeks prior to enrolment in the study 7.Cases already undergoing homeopathic treatment for any chronic disease since last 6 months8.Substance abuse and/or dependence9.Pregnant, puerperial or lactating women10.Patients with psychiatric diseases11.Self-reported immune-compromised states
12.Vulnerable population – Unconscious, non-ambulatory, too ill for consultation, differently abled, terminally ill or critically ill patients, mentally disabled people13.Simultaneous participation in any other clinical trial
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method